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Received May 14, 2013; accepted August 22, 2013AbstractBackground: Acute liver damage is primarily induced by one of several causes, among them viral exposure, alcohol consumption, and drug and
immune system issues. Agents with the ability to inhibit tyrosinase and protect against DNA damage caused by reactive oxygen species (ROS)
may be therapeutically useful for the prevention or treatment of ROS-related diseases.
Methods: This investigation examined the hepatoprotective effects of phloretin and phloretin isonicotinyl hydrazone (PIH) on D-galactosamine
(D-GalN)-induced acute liver damage in Kunming mice, as well as the possible mechanisms. The serum levels of alanine aminotransferase
(ALT), aspartate aminotransferase (AST), g-glutamyl transferase (g-GT), alkaline phosphatase (ALP), and total bilirubin (TB) as well as the
histopathological changes in mouse liver sections were determined. The antioxidant effects of phloretin, quercetin, and PIH on lipid peroxidation
in rat liver mitochondria in vitro, 1,1-diphenyl-2-picrylhydrazyl (DPPH) or 2,2-azino-bis-(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) free
radical scavenging activity in vitro, and supercoiled pBR322 plasmid DNA were confirmed. The experiment also examined the antityrosinase
activity, inhibition type, and inhibition constant of phloretin and PIH.
Results: Phloretin, quercetin, or PIH significantly prevented the increase in serum ALT, AST, g-GT, ALP, and TB in acute liver damage induced
by D-GalN, and produced a marked reduction in the histopathological hepatic lesions. Phloretin, quercetin, or PIH also exhibited antioxidant
effects on lipid peroxidation in rat liver mitochondria in vitro, DPPH or ABTS free radical scavenging activity in vitro, and supercoiled pBR322
plasmid DNA. Phloretin, quercetin, or PIH also exhibited good antityrosinase activity.
Conclusion: To the best of our knowledge, this was the first study of the hepatoprotective effects of phloretin and PIH on D-GalN-induced acute
liver damage in Kunming mice as well as the possible mechanisms. This was also the first study of the lipid peroxidation inhibition activity of
phloretin and PIH in liver mitochondria induced by the Fe2þ/vitamin C (Vc) system in vitro, the protective effects on supercoiled pBR322
plasmid DNA, and the antityrosinase activity of phloretin and PIH.
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Acute liver damage is mainly induced by a virus, alcohol,
drugs, and immune system issues. The main treatment mea-
sures include administration of antioxidants and suitable
support treatment. Aspartate aminotransferase (AST), alanine
aminotransferase (ALT), g-glutamyl transferase (g-GT),
alkaline phosphatase (ALP), and total bilirubin (TB) are thehinese Medical Association. All rights reserved.
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Galactosamine (D-GalN) is the interference agent of uridine
diphosphate (UDP) in liver cells. UDP-D-GalN can hinder the
biosynthesis of nucleic acid, glycoprotein, and glycogen.
Finally, D-GalN can cause injury to and necrosis of liver cells,
which is a common model used to observe the hep-
atoprotective effects of drugs.1,2
Phloretin is a type of flavonoid that has beneficial anti-
cancer and antioxidant properties, and is primarily derived
from various species of apple. Phloretin isonicotinyl hydra-
zone (PIH) is a new compound synthesized by our team,
which has more antioxidant activity than phloretin.3 Phloretin,
whose molecular formula is C15H14O5, is a di-hydrogen-
chalcone flavonoid. Phloretin can fade melanin, making the
skin whiten, with proven effects superior to kojic acid and
arbutin. Additionally, phloretin is commonly used as a new
type of whitening agent in cosmetics, and has many biological
applications, including antioxidant activity.4e8
This experiment examined the hepatoprotective effects of
phloretin and PIH on D-GalN-induced acute liver damage in
Kunming mice as well as the possible mechanisms. The serum
levels of ALT, AST, g-GT, ALP, and TB and histopathological
changes in mouse liver sections were determined. The antioxi-
dant effects of phloretin, quercetin, or PIH on lipid peroxidation
in rat liver mitochondria in vitro, 1,1-diphenyl-2-picrylhydrazyl
(DPPH) or 2,2-azino-bis-(3-ethylbenzthiazoline-6-sulphonic
acid) (ABTS) free radical scavenging activity in vitro, and
supercoiled pBR322 plasmid DNA were also determined. The
experiment also examined the antityrosinase activity, inhibition
type, and inhibition constant of phloretin, quercetin, or PIH.
2. Methods2.1. AnimalsMale and female Kunming mice (weighing 20e25 g),
Sprague Dawley (SD) rats (weighing 200e220 g), and their
food were obtained from the Experimental Animal Center of
Jiangxi University of Traditional Chinese Medicine (Jiangxi,
China). They were allowed free access to water and food. All
the animals were housed in a room maintained at a tempera-
ture of 23 3C and a relative humidity of 50 10%, with
artificial lighting from 8:00 AM to 8:00 PM for 1 week before
and during the experiments. All experiments were performed
in accordance with the Regulations of Experimental Animal
Administration issued by the State Committee of Science and
Technology of the People’s Republic of China.2.2. Chemicals and reagentsDiagnostic kits for ALT, AST, g-GT, ALP, and TB were
obtained from the Nanjing Jiancheng Bioengineering Institute
(Nanjing, China). Also, a C3606 organization mitochondria
separation reagent kit was purchased from Biyuntian
(Shanghai, China). D-GalN, phloretin, quercetin, DPPH, thi-
obarbituric acid (TBA), and ABTS were purchased from the
Sigma Chemical Company (St. Louis, MO, USA). PIH is anew compound synthesized by our team, whose purity is more
than 95%. Sodium dihydrogen phosphate, disodium phos-
phate, ferrous sulfate, potassium sulfate, and potassium per-
sulfate (K2S2O8) were of analytical grade and purchased from
Sinopharm Chemical Reagent Co., Ltd (Shanghai, China). All
other chemicals and solvents were of analytical grade and
commercially available.2.3. Synthesis and characterization of PIHPhloretin (5.4854 g, 20 mmol) and isoniazid (2.8802 g,
21 mmol) were placed in a triple-neck flask and dissolved with
5 mL of ethanol. Subsequently, 50 mL of toluene and 0.5 g of
p-toluene sulfonic acid were added and allowed to react for
48 hours. The synthesis route is shown in Fig. 1A. The liquid
was separated three times using 40e70 mm silica gel column
chromatography. The elution agents were composed of 20:1
ethyl acetate/methanol. Thin layer chromatography was car-
ried out to detect PIH. The second component was collected
and vacuum-dried to a constant weight.
A Hitachi L-2000 high-performance liquid chromatography
(HPLC) instrument (Tokyo, Japan) and an Autima reversed-
phase chromagraphy column (Tokyo, Japan) were used for the
HPLC of PIH. The mobile phase was composed of 45%
acetonitrile and 55% water. The volume of each sample was
10 mL and the wavelength used was 310 nm. The samples for
the infrared (IR) spectrum were prepared via the potassium
bromide method. The IR spectrum of PIH was measured
within the scope of 400e4000 cm1 using a Fourier transform
infrared spectrometer (Tokyo, Japan). The hydrogen-1 nuclear
magnetic resonance (NMR) and Carbon-13 NMR data and the
HPLC and IR profiles of PIH were shown in the report.3 The
yield efficiency of PIH was 68 5.3%.2.4. D-GalN-induced hepatotoxicity modelMice were randomly divided into seven groups of eight
animals (4 males and 4 females) each. In the control group and
D-GalN-intoxicated group, animals were given a single dose
of distilled water [0.4 mL/20 g, intragastrically (ig)] daily. In
the test groups, animals were given phloretin or quercetin or
PIH (0.877 or 1.754 mmol/kg, 0.4 mL/20 g, ig) once daily. All
administrations were conducted for 7 consecutive days. On the
7th day, all mice except those in the control group were
simultaneously given a D-GalN/water mixture (800 mg/kg,
0.2 mL/20 g, intraperitoneally) 1 hour after the last adminis-
tration, whereas the control group received only distilled
water. Then, all animals were fasted for 16 hours and were
subsequently tested for the following analysis. Because the
molecular weights of these three compounds are different, the
same unit mmol was used to determine comparative pharma-
codynamics. For example, 0.877 mmol/kg or 1.754 mmol/kg
phloretin means 240.3 mg/kg or 480.6 mg/kg, whereas
0.877 mmol/kg or 1.754 mmol/kg quercetin means 265 mg/kg
or 530 mg/kg. Because the newly synthesized pure compound
PIH was obtained with great difficulty, only 0.877 mmol/kg
(344.7 mg/kg) PIH was used.
Fig. 1. (A) The synthesis of PIH. (B) The effects of phloretin, quercetin, and PIH on serum ALT activity after D-GalN treatment in mice. (C) The effects of
phloretin, quercetin, and PIH on serum AST activity after D-GalN treatment in mice. ###p< 0.001, compared with the control group. *p< 0.05 and **p< 0.01,
compared with the D-GalN-intoxicated group. ALT ¼ alanine aminotransferase; AST ¼ aspartate aminotransferase; D-GalN ¼ D-galactosamine; PIH ¼ phloretin
isonicotinyl hydrazone.
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liver functionBlood was taken for analysis to check ALT, AST, g-GT,
ALP, and TB levels, which were determined with commer-
cially available diagnostic kits from Nanjing Jiancheng
(Nanjing, China). Differences among the means were analyzed
by one-way analysis of variance (ANOVA), and p< 0.05 was
considered statistically significant (SPSS version 13.0; SPSS
Inc., Chicago, IL, USA).2.6. Histopathological examinationsAportion of the left lobe of the liverwas preserved in formalin
solution (10%) for histopathological sections. The fixed tissues
were embedded in paraffin. The tissue slices with 3e5 mm
thickness were deparaffinized, dehydrated in ethanol
(50e100%), and cleared by xylene. The extent of D-GalN-
induced damage was evaluated by the morphological changes in
liver sections stained with hematoxylin and eosin (H&E) under
an Olympus light microscope. The images were examined by the
Olympus BX50 light microscope. The data were analyzed by the
image analysis system MetaMorph Offline (UIC/OLYMPUS).2.7. DPPH free radical scavenging capacityWith reference to the method of Lee et al9 and Wan et al,10
the reaction system was amended to the following steps. In thetube, 1 mL of tested samples in turn were added in different
concentrations; 0.5 mL of 0.6 mmol/L DPPH methanol solu-
tion and 3.5 mL of ethanol were added. The reaction lasted
30 minutes in room temperature, in a dark environment. The
wavelength used was 517 nm, and each sample was measured
in triplicate and averaged. The activity was calculated ac-
cording to the following formula:
DPPH scavenging activity ð%Þ ¼ ½ðAC ASÞ=AC  100%
ð1Þ
where AC is the absorbance value of the control and AS is the
absorbance value of the added test samples solution.2.8. ABTS free radical scavenging capacityWith reference to the method of Re et al,11 with some
modifications, the reaction system was amended by the
following steps. ABTS was dissolved in water to make a
concentration of 7 mmol/L. ABTSþ was produced by reacting
the ABTS stock solution with 2.45 mmol/L K2S2O8 and
allowing the mixture to stand in the dark at room temperature
for 12e16 hours prior to use. The ABTSþ stock solution was
diluted with methanol until the absorbance at 734 nm was
0.70 0.02.
Five mL of diluted ABTSþ was added to 0.5 mL of diluted
samples for 6 minutes. The activities of the samples were
evaluated by comparison with a control (containing 5 mL of
Fig. 2. (A) The effects of phloretin, quercetin, and PIH on serum g-GT activity after D-GalN treatment in mice. (B) The effects of phloretin, quercetin, and PIH on
serum ALP activity after D-GalN treatment in mice. (C) The effects of phloretin, quercetin, and PIH on serum TB activity after D-GalN treatment in mice.
###p< 0.001, compared with the control group. *p< 0.05, **p< 0.01, and ***p< 0.001, compared with the D-GalN-intoxicated group. ALP ¼ alkaline
phosphatase; D-GalN ¼ D-galactosamine; g-GT¼ g-glutamyl transferase; PIH ¼ phloretin isonicotinyl hydrazone; TB ¼ total bilirubin.
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measured in triplicate and averaged. This ABTSþ scavenging
activity was calculated by the following formula:
ABTSþ scavenging activity ð%Þ ¼ ½ðAC ASÞ=AC  100%
ð2Þ
where AC is the absorbance value of the control and AS is the
absorbance value of the added test samples solution.2.9. Lipid peroxidation assay in liver mitochondria
in vitro
2.9.1. Isolation of SD rats liver mitochondria
Liver mitochondria were obtained by commercially avail-
able diagnostic kits from Biyuntian (Shanghai, China). The
livers of SD rats were obtained and cut into very small pieces.
Then, cold mitochondria separation reagent A was added to
the liver pieces. Livers were removed and homogenized (1:2
w/v) in an ice-cold phosphate buffer (50 mM, pH 7.4) con-
taining 0.1 mM EDTA. The homogenate was centrifuged at
40.32g for 5 minutes at 4C. Subsequently, the supernatant
was centrifuged at 13,552g for 10 minutes at 4C. Themitochondria pellet was resuspended in the phosphate buffer
(2 g liver/mL, 1e1.3 mg protein/mL), and stored at 80C.
Prior to use, the mitochondria were thawed and washed twice
with ice-cold TriseHCl buffer (50 mM, pH 7.4) containing
150 mM KCl, followed by centrifugation at 11,000 rpm for
10 minutes at 4C. Finally, the pellet was resuspended in 4 mL
TriseHCl buffer and then used.122.9.2. Lipid peroxidation assay
In the tubes, 0.5 mL of antioxidant solution, 1 mL of
mitochondria liquid, 0.25 mL of 0.1 mM Fe2þ, and 0.25 mL of
1 mM vitamin C were added in turn. Phosphate-buffered saline
(PBS; 0.05 M, 0.5 mL) was added to the positive control group
instead of the 0.5 mL of antioxidant solution. Only 1 mL of
0.05 M PBS buffer and 1 mL of mitochondrial liquid was added
to the control group. The test tubes were placed at 37C for
1 hour, then 2 mL of 20% CCl3COOH and 2.5% hydrochloric
acid solution were added for 10 minutes, followed by 2 mL of
0.67% TBA and 0.3% NaOH solution. The test tubes were
placed in the water at 95C for 30 minutes, then centrifuged at
1372g for 10 minutes. The wavelength used was 532 nm. Each
sample was measured three times and averaged.
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Lipid peroxidation inhibition activity ð%Þ
¼ ½ðAC ASÞ=AC  100% ð3Þ
where AC is the absorbance value of the positive control group
and AS is the absorbance value of the added test samples
solution.2.10. Supercoiled pBR322 plasmid DNA assayThe assay was conducted following the procedure
described previously with slight modification.13 Briefly,
100 ng of pBR322 DNA was incubated with 10 mM 2,20-
azobis(2-methylpropionamidine)dihydrochloride (AAPH) in
PBS (pH 7.4) to a final volume of 25 mL (i.e., 5 mL DNA,
15 mL AAPH, 5 mL antioxidants; in the absence of antioxi-
dants, 5 mL distilled water was used) in microcentrifuge tubes
for 1 hour at 37C. After incubation, the samples were mixed
with 2 mL 10 loading buffer, immediately loaded into a
0.8% agarose gel stained with 0.8 mL gold view, and elec-
trophoresed in a horizontal slab gel apparatus in 1 tris-ace-
tate-ethylenediaminetetraacetic acid (TAE) gel buffer for
75 minutes (50 V, 20 mA). The gels were then photographed
under UV transillumination using the Gel Doc XR system
(Bio-Rad) (New York, America). DNA strand breaks were
evaluated using the untreated DNA under the same incubation
conditions as the controls. Quantity One software (Bio-Rad)
was used to quantify the amount of supercoiled DNA.2.11. Tyrosinase activity assayTyrosinase activity assay was performed as previously
described with some modification.14 The tyrosinase activity
was measured using L-3,4-dihydroxyphenylalanine (L-
DOPA) as a substrate. Inhibitor samples were dissolved in
dimethyl sulfoxide (DMSO) at the concentrations needed,
and L-DOPA was dissolved in PBS buffer (pH 6.8) at 30C.
Then, 2.8 mL of L-DOPA (5 mM) was mixed with 0.1 mL of
sample. After 1 minute, 0.1 mL of the aqueous solution of
tyrosinase (5.33 mg/mL) was added to the mixture and the
absorbance was immediately monitored at 475 nm for 400
seconds. The slope of the linear part was regarded as relative
enzyme activity. The inhibitory concentration 50 (IC50)
values, which represent the effective concentration at which
50% of enzyme activity was inhibited, were calculated to
evaluate the antityrosinase activity of the different com-
pounds. Quercetin was used as a positive control. All mea-
surements were performed at least in triplicate. The
inhibitory rate was calculated according to the formula:
Inhibitory rate ð%Þ ¼ ½ðS0  S1Þ=S0  100% ð4Þ
where S0 is the slope of the control (without samples) and S1 is
the slope in the presence of the samples.2.12. Determination of the inhibition type and inhibition
constantThe inhibition type was assayed by Lineweaver-Burk plot,
and the inhibition constant was determined by the second plots
of the apparent Km/Vmapp or 1/Vmapp versus the concentration
of the inhibitor.
3. Results3.1. Effects of phloretin, quercetin, and PIH on serum
ALT and AST activityThe results of the hepatoprotective effect of phloretin,
quercetin, and PIH on serum ALT and AST activity are
shown in Fig. 1B and C. In the D-GalN-intoxicated group,
serum ALT and AST activities were 341.19 31.35 units/L
(n¼ 8, p< 0.001) and 332.91 30.74 units/L (n¼ 8,
p< 0.001), respectively, whereas these values were only
23.07 4.39 units/L and 31.52 10.11 units/L (n¼ 8),
respectively, in the control group. These data indicated that
D-GalN can severely damage the membrane of liver cells,
causing a large number of ALT and AST enzymes to be
released into the blood. Moreover, the elevated levels of
serum ALT and AST were significantly reduced (p< 0.05) in
the groups pretreated with phloretin, quercetin, and PIH
(1.754 mmol/kg and 0.877 mmol/kg), and this reduction was
dose-dependent. The activity order from the strongest to the
weakest was PIH, quercetin, and phloretin at the same con-
centration of 0.877 mmol/kg. The group descriptions in the
figures can be identified as different color columns. The
statistical difference between low and high dose of treated
compound is p< 0.05. Furthermore, the low dose showed
significant improvement.3.2. Effects of phloretin, quercetin, and PIH on serum g-
GT and ALP activityThe results of the hepatoprotective effect of phloretin,
quercetin, and PIH on serum g-GT and ALP activity are
shown in Fig. 2A and B. In the D-GalN-intoxicated group,
the serum g-GT activity was 216.19 41.86 units/L (n¼ 8,
p< 0.001), whereas the value was only 60.70 11.63 units/L
(n¼ 8) in the control group. In the D-GalN-intoxicated
group, the serum ALP activity was 33.69 3.74 King units/
100 mL (n¼ 8, p< 0.001), whereas the value was only
8.93 1.32 King units/100 mL (n¼ 8) in the control group.
These data indicated that D-GalN can severely damage the
membrane of liver cells, also causing a large number of g-
GT and ALP enzymes to be released into the blood. More-
over, the elevated levels of serum g-GT and ALP were
significantly reduced (p< 0.05) in the groups pretreated with
phloretin, quercetin, and PIH (1.754 mmol/kg and
0.877 mmol/kg), and this reduction was dose-dependent. The
activity order from the strongest to the weakest was PIH,
quercetin, and then phloretin, at the same concentration of
0.877 mmol/kg.
Fig. 3. The effects of phloretin, quercetin, and PIH on the liver histological damage after D-GalN treatment in mice. A portion of the left lobe of the liver tissues
stained with H&E was used for histological assessment under a microscope. Representative photographs of liver sections stained with H&E showing the path-
ological changes in hepatic tissues under microscopy (400): (A) control group; (B) D-GalN-intoxicated group; (C) quercetin 1.754 mmol/kg and D-GalN group;
(D) phloretin 0.877 mmol/kg and D-GalN group; (E) PIH 0.877 mmol/kg and D-GalN group; (F) quercetin 0.877 mmol/kg and D-GalN group; (G) control group
(100); and (H) D-GalN-intoxicated group (100). The low power fields were used to show both the portal area and central area, which are important for realizing
the extent and degree of liver damage. D-GalN ¼ D-galactosamine; H&E ¼ hematoxylin and eosin; PIH ¼ phloretin isonicotinyl hydrazone.
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TB activityThe results of the hepatoprotective effect of phloretin,
quercetin, and PIH on serum TB activity are shown in
Fig. 2C. In the D-GalN-intoxicated group, the serum TB
activity was 364.66 43.32 mmol/L (n¼ 8, p< 0.001),
whereas the value was only 132.99 13.68 mmol/L (n¼ 8)
in the control group. These data indicated that D-GalN cansignificantly damage the membrane of liver cells, causing
a large number of TB to be released into the blood.
Moreover, the elevated levels of the serum TB were
significantly reduced (p< 0.05) in the groups pretreated
with phloretin, quercetin, and PIH (1.754 mmol/kg and
0.877 mmol/kg), and this reduction was dose-dependent.
The activity order from the strongest to the weakest was
PIH, quercetin, and then phloretin, at the same concen-
tration of 0.877 mmol/kg.
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Fig. 4. (A) The relationship between final concentration and the ratio of scavenging DPPH radicals. The IC50 values of scavenging DPPH free radical of PIH,
quercetin, and phloretin were 2.5 mmol/L, 4 mmol/L, and 10 mmol/L, respectively (n ¼ 3, p< 0.05). (B) The relationship between final concentration and the ratio
of scavenging ABTS radicals. The IC50 values of scavenging ABTS free radical of PIH, quercetin, and phloretin were 2.27 mmol/L, 3.64 mmol/L, and 4.54 mmol/L,
respectively (n ¼ 3, p< 0.05). (C) The relationship between final concentration and the ratio of inhibiting lipid peroxidation. The IC50 values of inhibiting lipid
peroxidation of PIH, quercetin, and phloretin were 2.08 mmol/L, 6.67 mmol/L, and12.5 mmol/L, respectively (n ¼ 3, p< 0.01). ABTS ¼ 2,2-azino-bis-(3-eth-
ylbenzthiazoline-6-sulphonic acid); DPPH ¼ 1,1-diphenyl-2-picrylhydrazyl; IC50 ¼ inhibitory concentration 50; PIH ¼ phloretin isonicotinyl hydrazone.
296 A.-R. Zuo et al. / Journal of the Chinese Medical Association 77 (2014) 290e3013.4. Histopathological observationsHistological assessment was used to complete the study of
the hepatoprotective effects of phloretin, quercetin, and PIH
on D-GalN-induced acute liver damage (Fig. 3). The histology
of the liver sections of control animals showed normal hepatic
cells with well-preserved cytoplasm, prominent nucleus and
nucleolus, and visible central veins. The liver sections of D-
GalN-intoxicated mice revealed extensive liver injuries,
characterized by moderate to severe hepatocellular degenera-
tion and necrosis around the central vein, serious gore in the
liver blood sinus, inflammatory cell infiltration, ballooning
degeneration, and the loss of cellular boundaries. However, the
histopathological hepatic lesions were markedly ameliorated
by pretreatment with phloretin, quercetin, and PIH. This was
consistent with the results of serum ALT, AST, g-GT, ALP,
and TB (Figs. 1 and 2).3.5. DPPH free radical scavenging capacityFig. 4A shows that PIH, quercetin, and phloretin all had
significant activity in scavenging DPPH free radicals at the
suitable concentration. The IC50 values of scavenging DPPH
free radical of PIH, quercetin, and phloretin were 2.5 mmol/L,
4 mmol/L, and 10 mmol/L (n¼ 3), respectively. The activity
order from the strongest to the weakest was PIH, quercetin,
and phloretin.3.6. ABTS free radical scavenging capacityFig. 4B shows that PIH, quercetin, and phloretin had sig-
nificant activity in scavenging ABTS free radicals at the
suitable concentration. The IC50 values of scavenging ABTS
free radicals of PIH, quercetin, and phloretin were 2.27 mmol/
L, 3.64 mmol/L, and 4.54 mmol/L (n¼ 3), respectively. The
Fig. 5. (A) Agarose gel electrophoretic patterns of supercoiled pBR322 plasmid DNA converted into the open circular by AAPH in the presence or absence of
samples. (B) The effects of samples on supercoiled pBR322 plasmid DNA converted into the open circular by AAPH in the presence or absence of samples. Lane
1: AAPH; lane 5: control (native pBR322 DNA, without AAPH); lanes 2e4: AAPH in the presence of samples at final concentrations of 2.5 mM, 5 mM, and 10 mM,
respectively. The density of the supercoiled DNA form was quantified by Quantity One (Bio-Rad). Data are the average of three determinations. AAPH ¼ 2,2’-
azobis(2-methylpropionamidine) dihydrochloride; C ¼ open circular; S ¼ supercoil.
Fig. 6. (A) The inhibition effects of quercetin, phloretin, and PIH on the diphenolase activity of mushroom tyrosinase. The IC50 values of quercetin, phloretin, and
PIH against tyrosinase were 25 mM, 37.5 mM, and 50 mM, respectively (n ¼ 5, p< 0.05). The order of activity was: quercetin> phloretin> PIH. (B) Determination
of the inhibitory mechanism of PIH on mushroom tyrosinase. The concentrations of PIH for curves 1e5 were 0 mmol/L, 12.5 mmol/L, 25 mmol/L, 50 mmol/L, and
100 mmol/L, respectively. IC50 ¼ inhibitory concentration 50; PIH ¼ phloretin isonicotinyl hydrazone.
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Fig. 7. Lineweaver-Burk plots for the inhibition of PIH on mushroom tyrosinase for the oxidation of L-DOPA. (A) The concentrations of PIH for curves 1e5 were
0 mmol/L, 12.5 mmol/L, 25 mmol/L, 50 mmol/L, and 100 mmol/L, respectively. (B) The plot of slope versus the concentration of PIH for determining the inhibition
constants KI. (C) The plot of intercept versus the concentration of PIH for determining the inhibition constants KIS. KI ¼ equilibrium constant for inhibitor binding
with free enzyme; KIS ¼ enzymesubstrate complex; L-DOPA ¼ L-3,4-dihydroxyphenylalanine; PIH ¼ phloretin isonicotinyl hydrazone.
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quercetin, and phloretin.3.7. Lipid peroxidation assay in liver mitochondria
in vitroFig. 4C shows that PIH, quercetin, and phloretin had sig-
nificant activity in inhibiting lipid peroxidation at suitable
concentrations. The IC50 values of inhibiting lipid peroxida-
tion of PIH, quercetin, and phloretin were 2.08 mmol/L,
6.67 mmol/L, and 12.5 mmol/L (n¼ 3), respectively. The ac-
tivity order from the strongest to the weakest was PIH, quer-
cetin, and phloretin.3.8. Supercoiled pBR322 plasmid DNA assayAs shown in Fig. 5A, the plasmid DNA was mainly super-
coiled in the absence of AAPH. With the addition of 10 mM
AAPH, the supercoiled form of DNA was converted into the
open circular and linear forms. After the incubation of the
plasmid DNA with 10 mM AAPH in the presence of the
different compounds at final concentrations of 2.5 mM, 5 mM,
and 10 mM, respectively, DNA damage was found to be
inversely related to the concentration of the test compound. This
effect was shown by a decrease in the amount of the circular and
linear forms and a concomitant increase in the supercoiled form.
Quantity One software (Bio-Rad) was used to quantify the
amount of supercoiled DNA, and the observed values are shown
in Fig. 5B. Thus, these compounds provided dose-dependent
protection against AAPH-induced free radical damage. The
inhibition effects produced by these compounds (10 mM) are
shown in the order of activity: PIH> quercetin> phloretin.
The conversion of plasmid or bacteriophage DNA from the
supercoiled form to the open circular and further linear formsis used as an index of DNA damage.15 AAPH is water-soluble
and the rate of free radical generation from AAPH can be
easily controlled and measured. Thus, AAPH is extensively
used as a free radical initiator for biological studies. The
presence of AAPH causes strand breaks in pBR322 DNA.163.9. Tyrosinase activity assayL-DOPA was used as the substrate for the diphenolase ac-
tivity assay. The progress curve for the enzyme reaction was a
family of lines passing through the origin with different
slopes, which indicated the diphenolase activity. The results
showed that the lag period did not exist as enzyme catalysis
progressed in the oxidation of L-DOPA. Quercetin, phloretin,
and PIH exhibited a potent inhibitory effect on diphenolase
activity with dose dependence. The IC50 values of quercetin,
phloretin, and PIH on diphenolase activity were 25 mM,
37.5 mM, and 50 mM, respectively. The activity order was
quercetin> phloretin> PIH (Fig. 6A). Therefore, quercetin,
phloretin, and PIH had obvious inhibitory effects on the
diphenolase activity of mushroom tyrosinase.3.10. Inhibition mechanism of phloretin and PIH on the
diphenolase activity of tyrosinaseThe inhibitory mechanism of phloretin and PIH on tyrosi-
nase for oxidation of L-DOPA was studied. The inhibitors
showed the same behavior. The relationship between enzyme
activity and its concentration in the presence of phloretin and
PIH was tested. As shown in Fig. 6B for the inhibitor of PIH,
the plots of the remaining enzyme activity versus the con-
centration of the enzyme at different inhibitor concentrations
gave a family of straight lines, which all passed through the
origin. The presence of an inhibitor did not reduce the amount
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tivity. The results showed that phloretin and PIH were
reversible inhibitors of tyrosinase for the oxidation of L-
DOPA.
The inhibition type of phloretin and PIH was investigated
by LineweaverBurk double-reciprocal plots. In the presence
of PIH, the kinetics of the enzyme are shown in Fig. 7. The
plots of 1/v versus 1/[S] gave a family of straight lines with
different slopes that intercept in the second quadrant, indi-
cating that PIH was a competitiveuncompetitive mixed type
inhibitor (Fig. 7A). It can be presumed that both compounds
not only can combine with free enzymes, but can also combine
with enzymesubstrate complexes. The equilibrium constant
for inhibitor binding with free enzyme (KI) was obtained from
a plot of the slope (Km/Vmapp) versus the concentration of the
inhibitor (Fig. 7B), and the enzymesubstrate complex (KIS)
was obtained from a plot of the vertical intercept (1/Vmapp)
versus the concentration of inhibitor (Fig. 7C). The values of
KI and KIS were determined as 57.5 mM and 187.1 mM,
respectively. Because KIS>KI was in the inhibitors, the af-
finity of the inhibitors for the free enzyme is greater than that
of the inhibitor for the enzymesubstrate complex. By
contrast, phloretin was the same inhibitor type as PIH, and the
inhibitor constants (KI and KIS) were estimated to be 23.5 mM
and 129 mM, respectively.
4. Discussion
It is well-known that the contents of serum ALT, AST, g-
GT, ALP, and TB serve as parameters to demonstrate the
extent of hepatotoxicity in mice. The activities of AST and
ALT are most commonly used as biochemical markers of liver
damage.17 AST locates in the mitochondria whereas ALT lo-
cates in the cytoplasm. The activities of serum AST and ALT
indicate the degree of cell damage (AST) or the amount of
cells injured (ALT).
Liver damage induced by D-GalN is the most intensive
system for xenobiotic-induced oxidative hepatotoxicity. D-
GalN can induce focal necrosis of a whole hepatic lobule with
severe infiltration of neutrophilic leucocytes, but liver damage
can be thoroughly prevented by GdCl3 injection in the caudal
vein prior to D-GalN injection intraperitoneally in rats. Liver
damage and apoptosis induced by D-GalN and a small dose of
lipopolysaccharides (LPS) can be markedly alleviated via
treatment with tumor necrosis factor-a (TNF-a) antiserum.
Because TNF-a primarily stemmed from activated Kupffer
cells (KCs), the key role that KCs played in the liver damage
was thus confirmed.18,19
Lipid peroxidation in liver mitochondria in vitro is an
excellent model to study antioxidant activity. The Fe2þ/
vitamin C (Vc) system can induce lipid peroxidation in liver
mitochondria in vitro. Malondialdehyde (MDA) is the impor-
tant product of lipid peroxidation. Thiobarbituric acid reactive
substance (TBARS) is the product of MDA and TBA. TBARS
can indicate the extent of lipid peroxidation. Lipid peroxida-
tion is the oxidation degradation chain reaction of the unsat-
urated fatty acid. It will generate many types of free radicals,such as oxygen free radicals, fat-oxygen free radicals, and fat-
free radicals. In the terminal stage, it will generate many types
of small molecules, such as MDA, which can harm cells.20
Therefore, it may be beneficial to obtain adequate antioxi-
dants in one’s diet.
Phloretin can enhance adipocyte differentiation and adipo-
nectin expression in 3T3-L1 cells,21 suppress the stimulated
expression of endothelial adhesion molecules, and reduce the
activation of human platelets.22 Phloretin can also prevent the
UV-induced photodamage in human skin23 and inhibit the
oxidation of aqueous emulsions of omega-3 fatty acids and fish
oil. Therefore, phloretin is a natural antioxidant in food.24
Phloretin is an effective antioxidant for inhibiting the peroxi-
dation of nitroso anions and lipids, and it also has antitumor
functions. Phloretin can inhibit the proliferation of H-Ras
MCF10 A human breast tumor cells in a dose-dependent
manner.25 It can activate c-Jun N-terminal kinase (JNK), p38
extracellular signal regulating kinase, and apoptosis protease
(caspase-3), increase p53 and Bax, decrease bcl-xl, and induce
apoptosis. Phloretin can also induce the apoptosis of HT-29
colon cancer cells in a dose-dependent manner. The apoptosis
may be initiated by changes in the mitochondrial membrane
permeability and activation of cell apoptosis protease path-
ways.26 Additionally, phloretin can inhibit the proliferation of
Molt 4 human leukemia cells in vitro and fisher bladder cancer
cells in vivo. Through apoptosis experiments in melanoma B16-
4 A5 cells, human leukemia cells, and HL60 cells, Kobori
et al27,28 found that phloretin can inhibit the movement of
glucose sugar across the membrane and inhibit the activity of
protein kinase C, which leads to tumor cell apoptosis. Wu et al29
found that the mRNA expression level of the type II glucose
carrier in the cell membrane surface of human liver cancer cell
HepG2 was five times higher than the level in normal liver cells.
Phloretin can restrain the expression of the glucose carrier
in vitro or in the body of tumor-burdened severe combined
immunodeficiency (SCID) mice.
Acyl hydrazone compounds have several unique structure
features as follows: (1) they contain several coordination
atoms with strong coordination ability; (2) they contain co-
ordination atoms, such as nitrogen, oxygen, and sulfur atoms,
similar to the biological environment; and (3) their molecules
have a greater conjugated system, with a large second har-
monic generation coefficient. Acyl hydrazone compounds
have several pharmacological activities, such as antibacterial,
anti-inflammatory, antivirus, anti-oxidation, anticancer, and
antitumor. These findings inspired the research enthusiasm of
several chemists and biologists.30e33
Quercetin is called a 3,30,40,5,7-five hydroxyl flavonoid,
whose molecular formula is C15H10O7. Quercetin has broad
biopharmacological effects, such as antioxidant, directly
scavenging free radicals, and hepatoprotectivity effects.
The study of Chen34 is designed to investigate the intravenous
effect of quercetin on liver damage induced by ethanol in rats. It
may be deduced that quercetin, bymultiplemechanism interplay,
demonstrated a somewhat protective effect on liver damage
induced by ethanol in rats. The study of Domitrovic et al35
showed that rutin exerts stronger protection against nitrosative
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anti-inflammatory activities and antifibrotic potential than quer-
cetin, which may be attributed to the presence of a rutinoside
moiety at position 3 of the C ring. The study of Cı´ntia et al36
showed that quercetin may have a preventive effect on
thioacetamide-induced hepatotoxicity by modulating the oxida-
tive stress parameters and apoptosis pathway.
Quercetin can also significantly inhibit the growth of many
kinds of cancer cells such as Eca-109 cells, Lewis lung cancer,
human breast cancer cells, monoblastic leukemia, BEL-
7402 cells,37 stomach cancer A549 cells,38 colon cancer
cells,39 human oral squamous carcinoma cells (SCC-25),40 and
pancreatic tumor cells.41 Quercetin and isorhamnetin are the
main flavonoids from Sarcopyramis bodinieri var. deli-
cate,42e44 which belongs to the taxon family Mela-
stomataceae, and are mainly found in Jiangxi, Fujian, and
Taiwan.
The authors Zuo et al. also investigated the anticancer
mechanism in HepG2 cells treated with phloretin and PIH using
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte trazolium bro-
mide (MTT) assay, flow cytometric analysis, gel electrophoresis
analysis, Western blot analysis, and realtime polymerase chain
reaction (PCR). The results showed that phloretin and PIH
exhibited good anticancer activity at suitable concentrations.
The anticancer mechanisms were as follows: inhibition of cell
proliferation, blocking of cell proliferation in the G0/G1 phase
of the cell cycle, degradation of the genomic DNA into a DNA
ladder, reduction of the amount of human telomerase reverse
transcriptase (hTERT), p53 (mutational), and Bcl-2 proteins,
increase in the amount of Bax protein, and inhibition of the
hTERT mRNA expression in HepG2 cells.
Tyrosinase (EC 1.14.18.1) is known to be a key enzyme for
melanin biosynthesis.45 Melanin is the pigment responsible for
the color of human skin and hair; however, excessive accumu-
lation of melanin, due to the overexpression of tyrosinase, leads
to skin disorders such as age spots, freckles, melisma, and
malignant melanoma.46 In the food industry, tyrosinase is
responsible for the browning of fruits and vegetables, which
results in a shorter product shelf life and reducedmarket value.47
By contrast, reactive oxygen species (ROS) are likely to be
involved in some human physiopathologies and have been
attracting growing interest from the health sector over the past
few decades. Excessive amounts of ROS could induce peroxi-
dation ofmembrane lipids and oxidative damage of proteins and
DNA, which are generally associated with a wide variety of
chronic health problems such as cancer, cardiovascular disease,
and aging. Hence, agents with the ability to inhibit tyrosinase
and protect against the protein andDNAdamage caused byROS
may be therapeutically useful for the prevention or treatment of
melanin-related and ROS related diseases. Meanwhile, appli-
cations of tyrosinase inhibitors and antioxidants as preservatives
in the food industry and skin-protective ingredients in cosmetics
have also drawn increased attention.
In conclusion, phloretin, quercetin, or PIH significantly
prevented the increase in serum ALT, AST, g-GT, ALP, and
TB in acute liver damage induced by D-GalN, and produced amarked amelioration in the histopathological hepatic lesions.
Phloretin, quercetin, or PIH also exhibited antioxidant effects
on lipid peroxidation in rat liver mitochondria in vitro, DPPH
or ABTS free radical scavenging activity in vitro, and super-
coiled pBR322 plasmid DNA. Phloretin, quercetin, or PIH
also exhibited good antityrosinase activity.
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